Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
2024 Global Forecast for Branded Generics (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
India and Europe Generic Injectable Market - Industry Trends and Forecast to 2035
... a CAGR of 9.0% in the forecast period of 2024 to 2035. The India generic injectable market is expected to reach USD 19,298.93 million by 2035 from USD 7,128.62 million in 2023, growing with a ... Read More
-
Digital Dose Inhaler Market by Product (Dry Powder Inhalers, Metered Dose Inhalers), Type (Branded Medication, Generics Medication), Distribution, Application - Global Forecast 2023-2030
... in 2022 and expected to reach USD 1,046.61 million in 2023, at a CAGR 10.29% to reach USD 2,083.52 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital ... Read More
-
Specialty Generics Global Market Report 2024
... International plc; Akorn Operating Company LLC ; Mylan NV; MallInc.krodt Pharmaceuticals Specialty Generics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Global Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Respiratory, Diabetology and Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical and Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities, and Forecast, 2016-2030F
... and Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities, and Forecast, 2016-2030F The Global Generic Drugs market size was estimated at USD 335.65 billion in 2022 and is projected to ... Read More
-
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032
... Development And Manufacturing; Secondary Packagingb) By CRO Service: Preclinical; Phase I; Phase II; Phase III; Phase IV2)By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical CompaniesCovering: Lonza Group; Catalent Inc.; WuXi ... Read More
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
Global Pharmaceutical Logistics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Pharmaceutical Contract Manufacturing (3rd Edition), 2021-2030 Distribution by [A] business segment (API and FDF), [B] type of API (branded and generic), [C] type of FDF (oral solids, parenteral and others), [D] type of packaging form (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle-East and North Africa): Industry Trends and Global Forecasts
... (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, ... Read More
-
Global Super Generics Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Super Generics industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Super Generics. The report also introduces players in the industry ... Read More
-
Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032
... to reach USD 948.04 billion by 2032, according to a new study by Polaris Market Research. The report “Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By ... Read More
-
Plunkett's Health Care Industry Almanac 2024: Health Care Industry Market Research, Statistics, Trends and Leading Companies
... help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and metrics Industry employment numbers ... Read More
-
United States (US) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and ... Read More
-
Global Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include ... Read More
-
Cephalosporin Market Forecasts to 2030 – Global Analysis By Generation (First-generation Cephalosporin, Second-generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin and Fifth-generation Cephalosporin), Type (Branded and Generic), Route of Administration, Distribution Channel, Dosage Form, Application and End User and By Geography.
... User and By Geography. According to Stratistics MRC, the Global Cephalosporin Market is accounted for $16.00 billion in 2023 and is expected to reach $22.97 billion by 2030 growing at a CAGR of 5.3% during ... Read More
-
Diagnostics and Therapeutics for HIV: Global Markets
... historic drug sales, regulations, reimbursements, and patents. The scope of this report includes an overview of the global market scenario for the diagnosis and treatment of HIV, with base year data from 2022, estimations for ... Read More
-
Generic Drug Market Forecasts to 2030 – Global Analysis By Product Type (Super Generics, Biosimilar Generics and Simple Generic), Route of Administration, Drug Class, Indication, Application, Distribution Channel, End User and By Geography
... Stratistics MRC, the Global Generic Drug Market is accounted for $396.8 billion in 2023 and is expected to reach $604.5 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Generic medications ... Read More
-
Global Finasteride Market Size Study & Forecast, by Type (Branded, Generic), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies), by Application (Benign Prostatic Hyperplasia (BPH), Male pattern baldness), and Regional Analysis, 2023-2030
... 2023-2030 Global Finasteride Market is valued at approximately USD 377.31 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2023-2030. Finasteride is a ... Read More
-
Oral Antibiotics Market By Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, Others), By Spectrum of Activity (Broad-spectrum Antibiotic, Mid/Narrow-spectrum antibiotic), By Application (Community-acquired respiratory tract infections (CARTIs), Urinary tract infections (UTIs), Dental, Others), By Drug Origin (Natural, Semisynthetic, Synthetic), By Drug Type (Branded, Generic): Global Opportunity Analysis and Industry Forecast, 2023-2032
... By Drug Origin (Natural, Semisynthetic, Synthetic), By Drug Type (Branded, Generic): Global Opportunity Analysis and Industry Forecast, 2023-2032 The Oral Antibiotics Market was valued at $22,468.27 million in 2022 and is estimated to reach $28,819.98 ... Read More
-
U.S. Generic Injectables Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Application, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. generic injectables pharmaceutical contract manufacturing market size is expected to reach USD 5.39 billion by 2030, according to a new report by Grand View Research, Inc. The U.S. market is ... Read More
-
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 Including: 1) By Drug Class: Nerve Protective Therapy; Anti-Inflammatory Therapy; Neurotransmitter Based Therapy; Antioxidantes 2) By Treatment: Medication; Therapy 3) By Drug Type: Branded; Generic 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies 5) By End-User: Hospitals; Research Institutes; Specialty Clinics Covering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc.
... Hospital Pharmacy; Retail Pharmacy; Online Pharmacies5) By End-User: Hospitals; Research Institutes; Specialty ClinicsCovering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc. Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 from ... Read More
-
Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) - Global Forecast to 2030
... systems market is expected to reach $3.97 billion by 2030, at a CAGR of 15.6% from 2023 to 2030. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies ... Read More
-
Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032.
... API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032. Pharmaceutical ... Read More
-
Branded Generics Market - By Drug Class (Anti-hypertensive, Hormones, Antimetabolites), Application (Oncology, Cardiovascular Diseases), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacy), Global Forecast, 2023 - 2032
... an appreciable growth rate between 2023 and 2032. Government initiatives aimed at promoting generic products can have a stimulating effect on the market. In September 2023, the Swiss government approved changes to the Ordinance on ... Read More
-
Global Generic Drug Intermediates CDMO Services Market Growth (Status and Outlook) 2023-2029
... and recovery from influence of COVID-19 and the Russia-Ukraine War, the Plastics Colouration Masterbatch is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research ... Read More
Research Assistance
